MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT
Clinical trials for MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI reads brain scans to spot Parkinson's lookalikes
Diagnosis OngoingThis study tests an AI tool called AIDP that analyzes MRI scans to help diagnose Parkinson's disease and two similar conditions (MSA and PSP). Researchers at 21 sites will compare the AI's diagnosis to that of movement disorder specialists. The goal is to see if the tool can impr…
Matched conditions: MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT
Sponsor: University of Florida • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
New study maps disease progression in Parkinson's and MSA
Knowledge-focused OngoingThis study follows 150 people with early Parkinson's disease or Multiple System Atrophy (MSA) for up to 18 months. Researchers will measure changes in motor symptoms, quality of life, and biomarkers to better understand how these diseases progress. The goal is to gather informati…
Matched conditions: MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT
Sponsor: AskBio Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Gene therapy AB-1005: how safe is it years later?
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 132 people with Parkinson's disease or multiple system atrophy who previously received the gene therapy AB-1005. Researchers will track safety and how well the treatment works over the long term. No new treatments are given; it's purely observational.
Matched conditions: MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT
Sponsor: AskBio Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC